Cargando…

Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment

BACKGROUND: Accurate prediction of molecular property holds significance in contemporary drug discovery and medical research. Recent advances in AI-driven molecular property prediction have shown promising results. Due to the costly annotation of in vitro and in vivo experiments, transfer learning p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yue, Ni, Xinran, Wang, Zhihao, Feng, Weike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360281/
https://www.ncbi.nlm.nih.gov/pubmed/37479969
http://dx.doi.org/10.1186/s12859-023-05413-x
_version_ 1785076070036275200
author Wu, Yue
Ni, Xinran
Wang, Zhihao
Feng, Weike
author_facet Wu, Yue
Ni, Xinran
Wang, Zhihao
Feng, Weike
author_sort Wu, Yue
collection PubMed
description BACKGROUND: Accurate prediction of molecular property holds significance in contemporary drug discovery and medical research. Recent advances in AI-driven molecular property prediction have shown promising results. Due to the costly annotation of in vitro and in vivo experiments, transfer learning paradigm has been gaining momentum in extracting general self-supervised information to facilitate neural network learning. However, prior pretraining strategies have overlooked the necessity of explicitly incorporating domain knowledge, especially the molecular fragments, into model design, resulting in the under-exploration of the molecular semantic space. RESULTS: We propose an effective model with FRagment-based dual-channEL pretraining (FREL). Equipped with molecular fragments, FREL comprehensively employs masked autoencoder and contrastive learning to learn intra- and inter-molecule agreement, respectively. We further conduct extensive experiments on ten public datasets to demonstrate its superiority over state-of-the-art models. Further investigations and interpretations manifest the underlying relationship between molecular representations and molecular properties. CONCLUSIONS: Our proposed model FREL achieves state-of-the-art performance on the benchmark datasets, emphasizing the importance of incorporating molecular fragments into model design. The expressiveness of learned molecular representations is also investigated by visualization and correlation analysis. Case studies indicate that the learned molecular representations better capture the drug property variation and fragment semantics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05413-x.
format Online
Article
Text
id pubmed-10360281
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103602812023-07-22 Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment Wu, Yue Ni, Xinran Wang, Zhihao Feng, Weike BMC Bioinformatics Research BACKGROUND: Accurate prediction of molecular property holds significance in contemporary drug discovery and medical research. Recent advances in AI-driven molecular property prediction have shown promising results. Due to the costly annotation of in vitro and in vivo experiments, transfer learning paradigm has been gaining momentum in extracting general self-supervised information to facilitate neural network learning. However, prior pretraining strategies have overlooked the necessity of explicitly incorporating domain knowledge, especially the molecular fragments, into model design, resulting in the under-exploration of the molecular semantic space. RESULTS: We propose an effective model with FRagment-based dual-channEL pretraining (FREL). Equipped with molecular fragments, FREL comprehensively employs masked autoencoder and contrastive learning to learn intra- and inter-molecule agreement, respectively. We further conduct extensive experiments on ten public datasets to demonstrate its superiority over state-of-the-art models. Further investigations and interpretations manifest the underlying relationship between molecular representations and molecular properties. CONCLUSIONS: Our proposed model FREL achieves state-of-the-art performance on the benchmark datasets, emphasizing the importance of incorporating molecular fragments into model design. The expressiveness of learned molecular representations is also investigated by visualization and correlation analysis. Case studies indicate that the learned molecular representations better capture the drug property variation and fragment semantics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05413-x. BioMed Central 2023-07-21 /pmc/articles/PMC10360281/ /pubmed/37479969 http://dx.doi.org/10.1186/s12859-023-05413-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Yue
Ni, Xinran
Wang, Zhihao
Feng, Weike
Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
title Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
title_full Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
title_fullStr Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
title_full_unstemmed Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
title_short Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
title_sort enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360281/
https://www.ncbi.nlm.nih.gov/pubmed/37479969
http://dx.doi.org/10.1186/s12859-023-05413-x
work_keys_str_mv AT wuyue enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment
AT nixinran enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment
AT wangzhihao enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment
AT fengweike enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment